v3.26.1
Note 17 - Summary of Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2025
Summary of Disposal Groups [Member]  
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]

For the year ended December 31, 2025

 

Avenova

Asset

Divestiture

   

PhaseOne

Divestiture

   

DERMA

doctor

Divestiture

   

China

NeutroPhase

product line

   

Total

 

Net income, net of taxes

  $ 10,509     $ 530     $ —     $ 42     $ 11,081  

Net increase in cash, cash equivalents and restricted cash

    10,550       541       —       42       11,133  

As of and for the year ended December 31, 2024

 

Avenova

Asset

Divestiture

   

PhaseOne

Divestiture

   

DERMA

doctor

Divestiture

   

China

NeutroPhase

product line

   

Total

 

Current assets

  $ 1,179     $ 54     $ —     $ —     $ 1,233  

Other assets

    9       —       —       —       9  

Current liabilities

    1,147       43       —       —       1,190  

Net income (loss), net of taxes

    2,445       71       (989 )     —       1,527  

Net increase (decrease) in cash, cash equivalents and restricted cash

    2,412       68       864       (45 )     3,299